Pmv Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 1.53

PMVP Stock  USD 1.50  0.01  0.67%   
Pmv Pharmaceuticals' future price is the expected price of Pmv Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Pmv Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Pmv Pharmaceuticals Backtesting, Pmv Pharmaceuticals Valuation, Pmv Pharmaceuticals Correlation, Pmv Pharmaceuticals Hype Analysis, Pmv Pharmaceuticals Volatility, Pmv Pharmaceuticals History as well as Pmv Pharmaceuticals Performance.
To learn how to invest in Pmv Stock, please use our How to Invest in Pmv Pharmaceuticals guide.
  
Please specify Pmv Pharmaceuticals' target price for which you would like Pmv Pharmaceuticals odds to be computed.

Pmv Pharmaceuticals Target Price Odds to finish over 1.53

The tendency of Pmv Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 1.53  or more in 90 days
 1.50 90 days 1.53 
about 75.01
Based on a normal probability distribution, the odds of Pmv Pharmaceuticals to move over $ 1.53  or more in 90 days from now is about 75.01 (This Pmv Pharmaceuticals probability density function shows the probability of Pmv Stock to fall within a particular range of prices over 90 days) . Probability of Pmv Pharmaceuticals price to stay between its current price of $ 1.50  and $ 1.53  at the end of the 90-day period is about 10.97 .
Given the investment horizon of 90 days Pmv Pharmaceuticals has a beta of 0.81 indicating as returns on the market go up, Pmv Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Pmv Pharmaceuticals will be expected to be much smaller as well. Additionally Pmv Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Pmv Pharmaceuticals Price Density   
       Price  

Predictive Modules for Pmv Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pmv Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pmv Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.081.504.14
Details
Intrinsic
Valuation
LowRealHigh
1.354.377.01
Details
6 Analysts
Consensus
LowTargetHigh
12.0113.2014.65
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.28-0.27-0.26
Details

Pmv Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Pmv Pharmaceuticals is not an exception. The market had few large corrections towards the Pmv Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pmv Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pmv Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.0064
β
Beta against Dow Jones0.81
σ
Overall volatility
0.07
Ir
Information ratio -0.0042

Pmv Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pmv Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pmv Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Pmv Pharmaceuticals may become a speculative penny stock
Pmv Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (68.96 M) with profit before overhead, payroll, taxes, and interest of 0.
Pmv Pharmaceuticals currently holds about 277.43 M in cash with (55.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 84.0% of the company shares are owned by institutional investors
Latest headline from simplywall.st: Discover 3 US Penny Stocks With Market Caps Over 40M

Pmv Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pmv Stock often depends not only on the future outlook of the current and potential Pmv Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pmv Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding48 M
Cash And Short Term Investments203.1 M

Pmv Pharmaceuticals Technical Analysis

Pmv Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Pmv Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pmv Pharmaceuticals. In general, you should focus on analyzing Pmv Stock price patterns and their correlations with different microeconomic environments and drivers.

Pmv Pharmaceuticals Predictive Forecast Models

Pmv Pharmaceuticals' time-series forecasting models is one of many Pmv Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pmv Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Pmv Pharmaceuticals

Checking the ongoing alerts about Pmv Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pmv Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Pmv Pharmaceuticals may become a speculative penny stock
Pmv Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (68.96 M) with profit before overhead, payroll, taxes, and interest of 0.
Pmv Pharmaceuticals currently holds about 277.43 M in cash with (55.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 84.0% of the company shares are owned by institutional investors
Latest headline from simplywall.st: Discover 3 US Penny Stocks With Market Caps Over 40M

Additional Tools for Pmv Stock Analysis

When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.